David A. Siegel Milestone Pharmaceuticals Inc. Transaction History
Two Sigma Advisers, LP
- $42.8 Billion
- Q1 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 76,000 shares of MIST stock, worth $132,240. This represents 0.0% of its overall portfolio holdings.
Number of Shares
76,000Holding current value
$132,240% of portfolio
0.0%Shares
10 transactions
Others Institutions Holding MIST
# of Institutions
51Shares Held
16.8MCall Options Held
341KPut Options Held
70.3K-
Black Rock Inc. New York, NY4.97MShares$8.65 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY2.51MShares$4.36 Million0.03% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.45MShares$2.53 Million1.35% of portfolio
-
Alta Fundamental Advisers LLC New York, NY1.43MShares$2.48 Million0.56% of portfolio
-
Bml Capital Management, LLC Zionsville, IN1.14MShares$1.98 Million0.74% of portfolio
About Milestone Pharmaceuticals Inc.
- Ticker MIST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,010,900
- Market Cap $52.2M
- Description
- Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...